Tablets - 5 mg
Parkinsan contains the active substance trihexyphenidyl hydrochloride.
It is an antimuscarinic agent with similar effects as atropine. It exerts direct inhibitory effect on the parasimpatique nervous system by inhibiting the effects of acetylcholine. Parkinsan has also an antispasmodic effect on the smooth muscles.
Parkinsan – tablet 5 mg is indicated:
• as supportive treatment for all forms of parkinsonism (postencephalytic, artheriosclerotic and idiopathic);
• as adjuvant therapy when treating the above-mentioned forms of parkinsonism with levodopa. It helps in reducing muscle rigidity and increased salivation that accompanies parkinsonism;
• as adjuvant therapy when using levodopa to control extrapyramidal disorders due to central nervous system drugs.
